D
IDEX Biometrics ASA IDXAD
$0.001 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 2/13/2025Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D- from E+ on 2/13/2025 due to a substantial increase in the valuation index, solvency index and volatility index. Debt to equity declined from 1.91 to 0.08, and the quick ratio increased from 0.37 to 0.61.
E
Sell 10/9/2024Downgrade
IDEX Biometrics ASA (IDXAD) was downgraded to E+ from D- on 10/9/2024 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.72 to 1.91, and the quick ratio declined from 0.54 to 0.37.
D
Sell 8/2/2024Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D- from E+ on 8/2/2024 due to an increase in the valuation index and total return index.
E
Sell 7/2/2024Downgrade
IDEX Biometrics ASA (IDXAD) was downgraded to E+ from D- on 7/2/2024 due to a decline in the valuation index.
D
Sell 6/17/2024Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D- from E+ on 6/17/2024 due to an increase in the volatility index and valuation index.
E
Sell 10/13/2023Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D- on 10/13/2023 due to a decline in the total return index and volatility index.
D
Sell 9/27/2023Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D- from E+ on 9/27/2023 due to an increase in the volatility index.
E
Sell 9/8/2023Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D- on 9/8/2023 due to a decline in the volatility index and total return index.
D
Sell 8/21/2023Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D- from E+ on 8/21/2023 due to an increase in the total return index, solvency index and valuation index. The quick ratio increased from 2.13 to 2.25.
E
Sell 5/2/2023Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D- on 5/2/2023 due to a major decline in the solvency index and valuation index.
D
Sell 4/27/2023Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D- from E+ on 4/27/2023 due to an increase in the volatility index.
E
Sell 3/14/2023Downgrade
IDEX Biometrics ASA (IDXAD) was downgraded to E+ from D on 03/14/2023.
D
Sell 2/9/2023Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D from E+ on 02/09/2023.
E
Sell 2/8/2023Downgrade
IDEX Biometrics ASA (IDXAD) was downgraded to E+ from D on 02/08/2023.
D
Sell 1/13/2023Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 1/13/2023 due to an increase in the total return index and volatility index.
D
Sell 12/29/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 12/29/2022 due to a decline in the valuation index and volatility index.
D
Sell 12/14/2022Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 12/14/2022 due to an increase in the total return index and volatility index.
D
Sell 11/29/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 11/29/2022 due to a decline in the total return index and volatility index.
D
Sell 11/14/2022Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 11/14/2022 due to an increase in the growth index and total return index. Operating cash flow increased 19.55% from -$9.02M to -$7.26M, EBIT increased 2.25% from -$8.31M to -$8.12M, and earnings per share increased from -$0.0091 to -$0.0089.
D
Sell 10/24/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 10/24/2022 due to a decline in the volatility index and total return index.
D
Sell 10/7/2022Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 10/7/2022 due to an increase in the valuation index.
D
Sell 9/22/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 9/22/2022 due to a decline in the total return index and volatility index.
D
Sell 9/7/2022Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 9/7/2022 due to an increase in the volatility index.
D
Sell 8/19/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 8/19/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 7.45 to 6.7.
D
Sell 5/16/2022Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D from E+ on 05/16/2022.
E
Sell 5/13/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D on 5/13/2022 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.0083 to -$0.0273, operating cash flow declined 21.89% from -$6.3M to -$7.67M, and EBIT declined 20.98% from -$7.46M to -$9.03M.
D
Sell 5/4/2022Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from E+ on 5/4/2022 due to an increase in the growth index and valuation index.
E
Sell 5/1/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell 4/21/2022Upgraded
IDEX Biometrics ASA (IDXAD) was upgraded to D from E+ on 04/21/2022.
E
Sell 4/20/2022Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to E+ from D on 4/20/2022 due to a major decline in the total return index and volatility index.
D
Sell 11/23/2021Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell 11/8/2021Downgrade
IDEX Biometrics ASA (IDXAF) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.0081 to -$0.01, and EBIT declined 0.91% from -$7.39M to -$7.46M.
D
Sell 5/6/2021Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to D from E+ on 5/6/2021 due to a noticeable increase in the total return index.
E
Sell 5/3/2021Upgraded
IDEX Biometrics ASA (IDXAF) was upgraded to E+ from E on 5/3/2021 due to a major increase in the solvency index, growth index and valuation index. Total revenue increased 141.13% from $248 to $598, debt to equity declined from 0.07 to 0.06, and the quick ratio increased from 1.96 to 2.15.
E
Sell 3/1/2021None
IDEX Biometrics ASA (IDXAD) was downgraded to E from U on 03/01/2021.
Weiss Ratings